title: Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments.
abstract: This study quantified the interplay and gradient effects on GTV dose coverage for 3D CRT, dMLC IMRT, and VMAT SABR treatments for target amplitudes of 5-30 mm using 3DVH v3.1 software incorporating 4D Respiratory MotionSim (4D RMS) module. For clinically relevant motion periods (5 s), the interplay effect was small, with deviations in the minimum dose covering the target volume (D99%) of less than ± 2.5% for target amplitudes up to 30 mm. Increasing the period to 60 s resulted in interplay effects of up to ± 15.0% on target D99% dose coverage. The gradient effect introduced by target motion resulted in deviations of up to ± 3.5% in D99% target dose coverage. VMAT treatments showed the largest deviation in dose metrics, which was attributed to the long delivery times in comparison to dMLC IMRT. Retrospective patient analysis indicated minimal interplay and gradient effects for patients treated with dMLC IMRT at the NCCI.
authors.affiliation: North Coast Cancer Institute; Shoalhaven Cancer Care Centre. madelaine.tyler@sesiahs.health.nsw.gov.au.
authors.forename: Madelaine K
authors.initials: MK
authors.lastname: Tyler
mesh_terms: D000465:Algorithms; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery*; D009038:Motion; D016634:Radiosurgery; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*; D055425:Respiratory-Gated Imaging Techniques / Q000379:methods*; D012189:Retrospective Studies